These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 82280)

  • 1. Effects of IRA in vitro on T- and B-lymphocytes from peripheral blood of patients with connective tissue diseases.
    Kosaka S
    Tohoku J Exp Med; 1978 Oct; 126(2):151-7. PubMed ID: 82280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids.
    Nakai H; Morito T; Tanimoto K; Horiuchi Y
    J Rheumatol; 1977; 4(4):405-13. PubMed ID: 415139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of T-cells and B-cells in SLE and RA].
    Nakai H; Nakamura T; Tanimoto K
    Nihon Rinsho; 1978 Dec; 36(12):3945-50. PubMed ID: 311861
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characterization of subpopulations of circulating lymphocytes in patients with various connective tissue diseases (author's transl)].
    Abud-Mendoza C; Ruíz-Argüelles A; Díaz-Jouanen E; Alarcón-Segovia D
    Rev Invest Clin; 1979; 31(1):11-9. PubMed ID: 312520
    [No Abstract]   [Full Text] [Related]  

  • 6. [Surface markers of peripheral blood T- and B-lymphocytes in patients with rheumatoid diseases].
    Stankaitene DI; Redaitene EI; Rulis AK; Ianulevichiute NA
    Ter Arkh; 1981; 53(7):6-11. PubMed ID: 7027511
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.
    Diaz-Jouanen E; Bankhurst AD; Williams RC
    Arthritis Rheum; 1976; 19(2):133-41. PubMed ID: 1083239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells.
    Horwitz DA; Juul-Nielsen K
    Clin Exp Immunol; 1977 Dec; 30(3):370-8. PubMed ID: 304786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
    Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
    Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on antilymphocyte antibodies in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Winchester RJ; Winfield JB; Fu SM; Wernet P; Kunkel HG
    Rheumatology; 1975; 6():209-14. PubMed ID: 1081726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral administration of D-penicillamine on T- and B-lymphocytes in peripheral blood of rheumatoid patients.
    Kosaka S
    Tohoku J Exp Med; 1979 Nov; 129(3):233-9. PubMed ID: 316588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased EA-rosette formation by lymphocytes from patients with rheumatoid arthritis.
    Sharpin RK; Wilson JD
    Clin Exp Immunol; 1977 Aug; 29(2):205-12. PubMed ID: 908172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T-lymphocyte values in peripheral blood in systemic lupus erythematosus and similar nosological entities (progressive systemic sclerosis, rheumatoid arthritis, and mixed connective tissue disease) (author's transl)].
    Rovenský J; Jarosková L; Zitnan D; Pekábek J; Svejcar J
    Cas Lek Cesk; 1982 Mar; 121(12):370-4. PubMed ID: 6979391
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of tumor-specific cell-mediated cytotoxicity by immunoregulatory alpha-globulin and by immunoregulatory alpha-globulin-like peptides from cancer patients.
    Wang BS; Badger AM; Nimberg RR; Cooperband SR; Schmid K; Mannick JA
    Cancer Res; 1977 Sep; 37(9):3022-5. PubMed ID: 69489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative and qualitative impairment of immunoregulatory cells in the circulation of rheumatoid arthritic patients.
    Algom D; Jodouin CA; Dunne JV; McKendry RJ
    Scand J Rheumatol; 1984; 13(2):155-62. PubMed ID: 6610932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lymphocytotoxins of systemic lupus erythematosus (SLE) sera on T and B lymphocytes.
    Gergely P; Szegedi G; Szabó G; Fekete B; Petrányi G
    Acta Med Acad Sci Hung; 1975; 32(1):43-8. PubMed ID: 1086049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).
    Morimoto C
    Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte function in rheumatic disorders.
    Vaughan JH; Chihara T
    Arch Intern Med; 1975 Oct; 135(10):1324-8. PubMed ID: 1100001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of T- and B-lymphocytes in rheumatic diseases.
    Messner RP
    Arthritis Rheum; 1974; 17(4):339-46. PubMed ID: 4604228
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of human T-lymphocyte receptor for sheep erythrocytes in immunoregulatory alpha-globulin.
    Musatti CC; Daher S; Bernd LA; Mendes NF
    J Clin Immunol; 1983 Oct; 3(4):352-8. PubMed ID: 6197425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.